| scholarly article | Q13442814 |
| P50 | author | Ilaria Bellantuono | Q57414970 |
| Robert Graham G Russell | Q67903135 | ||
| P2093 | author name string | F Hal Ebetino | |
| Sindhu T Mohanty | |||
| James A Fernandes | |||
| Juhi Misra | |||
| Sanjeev Madan | |||
| P2860 | cites work | Gamma radiation induces senescence in human adult mesenchymal stem cells from bone marrow and periodontal ligaments. | Q53184654 |
| Differentiation-related response to DNA breaks in human mesenchymal stem cells | Q64386387 | ||
| Frequency of stromal lineage colony forming units in bone marrow of peroxisome proliferator-activated receptor-alpha-null mice | Q73315954 | ||
| Risk of pelvic fractures in older women following pelvic irradiation | Q23909178 | ||
| Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control | Q24314363 | ||
| mTOR is a key modulator of ageing and age-related disease | Q24610741 | ||
| FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis | Q24630630 | ||
| FoxO3 regulates neural stem cell homeostasis | Q24658086 | ||
| Lamin A-dependent nuclear defects in human aging | Q24681309 | ||
| Genomic instability in laminopathy-based premature aging | Q28258404 | ||
| Stem cell defects in ATM-deficient undifferentiated spermatogonia through DNA damage-induced cell-cycle arrest | Q28274220 | ||
| Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells | Q28288970 | ||
| Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB | Q28306356 | ||
| Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment | Q33701168 | ||
| Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index | Q33718131 | ||
| Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. | Q34009569 | ||
| Bisphosphonates: the first 40 years | Q34026820 | ||
| FoxO3a regulates hematopoietic homeostasis through a negative feedback pathway in conditions of stress or aging | Q34197553 | ||
| Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells. | Q34534085 | ||
| Zoledronic acid and clinical fractures and mortality after hip fracture | Q34689802 | ||
| Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies | Q34744250 | ||
| Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. | Q34790173 | ||
| Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation | Q34986627 | ||
| Stromal cells and stem cells in clinical bone regeneration | Q35116065 | ||
| A link between the accumulation of DNA damage and loss of multi-potency of human mesenchymal stromal cells | Q36516974 | ||
| Functional interaction between FOXO3a and ATM regulates DNA damage response | Q37171572 | ||
| Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability | Q37307982 | ||
| Potential mediators of the mortality reduction with zoledronic acid after hip fracture | Q37542295 | ||
| Radiation effects on bone healing and reconstruction: interpretation of the literature | Q37685568 | ||
| Biochemical and molecular mechanisms of action of bisphosphonates. | Q37812800 | ||
| Zoledronic acid use in cancer patients: more than just supportive care? | Q37828494 | ||
| The relationship between the chemistry and biological activity of the bisphosphonates. | Q37865849 | ||
| Charity begins at home: non-coding RNA functions in DNA repair | Q38079476 | ||
| Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial | Q38230839 | ||
| GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway | Q39458307 | ||
| Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism | Q39640617 | ||
| Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation. | Q39979667 | ||
| Irradiated bone and its management. | Q40944232 | ||
| A small molecule modulator of prion protein increases human mesenchymal stem cell lifespan, ex vivo expansion, and engraftment to bone marrow in NOD/SCID mice | Q45112584 | ||
| Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion | Q45877573 | ||
| Crif1 Promotes Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells After Irradiation by Modulating the PKA/CREB Signaling Pathway | Q46545780 | ||
| Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells. | Q46915466 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| DNA damage | Q5205747 | ||
| P304 | page(s) | 756-767 | |
| P577 | publication date | 2015-12-17 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Zoledronate Attenuates Accumulation of DNA Damage in Mesenchymal Stem Cells and Protects Their Function | |
| P478 | volume | 34 |
| Q41430322 | Co-Activation of PKC-δ by CRIF1 Modulates Oxidative Stress in Bone Marrow Multipotent Mesenchymal Stromal Cells after Irradiation by Phosphorylating NRF2 Ser40. |
| Q42368059 | Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells |
| Q47994742 | Effect of zoledronate, a third-generation bisphosphonate, on proliferation and apoptosis of human dental pulp stem cells |
| Q64974351 | Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts. |
| Q54223105 | Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease. |
| Q28074810 | Mesenchymal Stem Cells as a Prospective Therapy for the Diabetic Foot |
| Q52570408 | Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults. |
| Q38630699 | Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation |
| Q27333060 | Small molecule-driven direct conversion of human pluripotent stem cells into functional osteoblasts |
| Q47156108 | Targeting subchondral bone mesenchymal stem cell activities for intrinsic joint repair in osteoarthritis |
| Q41689098 | The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate). |
Search more.